GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Norris Medicines Ltd

Norris Medicines Appoints Iqubal Ismail Patel as CFO

BOARD ▲ Positive Development LOW RISK
📅 Filed on BSE: 30 Jul 2026, 06:17 PM IST  ·  BSE ID: fab7a19e-2a38-4ac9-a943-ecca8364c2e4
View Original BSE Filing (PDF)
💡
In Simple Terms
Norris Medicines has a new Chief Financial Officer, Mr. Iqubal Ismail Patel, starting today.
🤖 AI Summary
  • Norris Medicines appointed Mr. Iqubal Ismail Patel as Chief Financial Officer (CFO) and KMP.
  • The appointment is effective from July 30, 2026.
  • The board approved the appointment based on recommendations from audit and remuneration committees.
  • Remuneration terms are subject to mutual agreement between the CFO and the board.
🏢 How This Affects the Company
⚙️
Operational Impact
The appointment of a CFO and KMP signifies the company is structuring its leadership team for ongoing operations.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding this appointment.
👤
Who Is Affected
All shareholders are indirectly affected by the appointment of key management personnel who oversee financial operations.
🔍
Management Signal
The appointment signals adherence to corporate governance norms and builds the company's core management team.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Confirmation of CFO's remuneration package by the board.
Future financial results disclosures and commentary from new CFO.
Any further disclosures on KMP appointments or changes.
LOW RISK Appointment of a CFO is a routine corporate governance event.
💡 Investor Takeaway
Norris Medicines Limited has appointed Mr. Iqubal Ismail Patel as its Chief Financial Officer (CFO) and KMP, effective July 30, 2026. Remuneration to be mutually agreed.
❓ Frequently Asked Questions
Who has Norris Medicines appointed as Chief Financial Officer (CFO)?
Norris Medicines has appointed Mr. Iqubal Ismail Patel as the Chief Financial Officer (CFO) and Key Managerial Personnel (KMP).
When is the appointment of Mr. Iqubal Ismail Patel as CFO effective?
The appointment of Mr. Iqubal Ismail Patel as CFO is effective from July 30, 2026.
What are the terms of appointment for Norris Medicines' new CFO?
The terms and conditions, including remuneration, for Mr. Iqubal Ismail Patel are to be mutually agreed upon between him and the board of directors.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.